“…The compounds styraxlignolide B-F (14-18), taraxerol (19), syringin (20) Pastorova et al, 1997;Djerassi et al, 1955;Schroeder, 1968;Reinitzer, 1914Reinitzer, , 1921 Yoshikawa et al, 2000;Nakano et al, 1967aNakano et al, , b, 1969Kitagawa et al, 1974aKitagawa et al, , b, 1975Kitagawa et al, , 1980Sugiyama et al, 1967a, b Segal et al, 1964;Zehavi et al, 1986;Yayla et al, 2002;Anil, 1979 seeds 7-9, 54-59, 66, 67, 72, 124-130 Anil, 2003a, b;Anil, 1980;Segal et al, 1967;Ulubelen et al, 1976 S. paralleloneurum resin Reynolds, 1982;Schroeder, 1968;Reinitzer, 1914Reinitzer, , 1921Huang, 1999;Wang et al, 2006a,b to the control. Therefore the effect of compounds on the expression of type I procollagen, and the MMP-1 proteins (matrix metalloproteinases) in cultured human dermal fi broblasts was examined, and 23 increased the type I procollagen protein expression level by 518.9 18.0%, and decreased the MMP-1 protein expression level signifi cantly by an average of 62.1 8.3 % at 10 M, compared with the vehicle-treated controls cells.…”